Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06629077 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Brain Blood Vessel Responses to Changes in Blood Flow

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Jan 2027 → May 2027
See other at-risk trials from University of Wisconsin, Madison

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jan 2027 to May 2027
    • Eligibility criteria expanded, about 20 words
  2. Start date changed from estimate of Feb 2026 to Feb 26, 2026v11
  3. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v10
  4. Primary and study completion dates: Dec 2026 to Jan 2027
    • Start date: Jan 2026 to Feb 2026
    v9
  5. Start date: Nov 2025 to Jan 2026
    • Primary and study completion dates: Nov 2026 to Dec 2026
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Start date: Sep 2025 to Nov 2025v7
  2. Eligibility criteria expanded, about 31 wordsv6
  3. Start date: Jul 2025 to Sep 2025
    • Primary and study completion dates: Sep 2026 to Nov 2026
    v5
  4. Start date: Apr 2025 to Jul 2025
    • Primary and study completion dates: Aug 2026 to Sep 2026
    v4
  5. Eligibility criteria expanded, about 2 wordsv3
  6. Start date: Jan 2025 to Apr 2025v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Brain blood flow will be measured during a simulated postural change test and while breathing increased levels of carbon dioxide using magnetic resonance imaging.
Trial Details
NCT Number NCT06629077
Lead Sponsor University of Wisconsin, Madison
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions
(from sponsor)		 Magnetic Resonance Imaging, Cerebrovascular Circulation
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov